The clinical information you need, at your fingertips.

Medical News for You

EADV 2026

AI triaged suspected skin cancer alone, and rarely missed

An autonomous system discharged up to a third of urgent referrals with no clinician review, freeing significant dermatologist capacity. . .

Lancet Diabetes Endocrinol

EASD 2026: Amylin agonist delivers weight loss with fewer GI side effects

Phase 2 data suggest petrelintide may offer a well-tolerated alternative to incretin-based obesity therapies. . .

FDA

11h

FDA greenlights Emcitate, first treatment for MCT8 deficiency

The therapy addresses excess thyroid hormone exposure in a rare X-linked genetic disorder. . .

DHHS

13h

HHS broadens two-drug HIV treatment options in major guideline update

Updated recommendations expand use of dolutegravir/lamivudine and add new two-drug regimen options for selected patients. . .

JAMA Netw Open

16h

Postoperative opioid use falls with EHR-guided pain care

Patient education and care team prompts yielded a 10% reduction, while reported pain and physical function remained similar. . .

EASD 2026

17h

Novo, Lilly each claim an edge in GLP-1 dosing data

One analysis favors raising the semaglutide dose over switching, while the other favors tirzepatide over high-dose semaglutide. But neither is a head-to-head test. . .

FDA

19h

Juvmo becomes the first selective D1/D5 agonist for Parkinson disease

The novel dopamine receptor agonist offers a differentiated approach to motor symptom control with or without levodopa. . .

EASD 2026

20h

Blood pressure swings may signal hidden stroke and mortality risk

Visit-to-visit BP variability may provide prognostic information beyond average BP levels. . .

JAMA Netw Open

Bleeding risk rivals recurrent events after stroke in younger adults

About 1 in 10 young adults on long-term antithrombotic therapy experienced bleeding within 5 years. . .